SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-09-028173
Filing Date
2009-05-01
Accepted
2009-05-01 07:01:23
Documents
9
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a09-11040_110q.htm 10-Q 1017746
2 EX-10.1 a09-11040_1ex10d1.htm EX-10.1 88875
3 EX-10.2 a09-11040_1ex10d2.htm EX-10.2 137390
4 EX-10.3 a09-11040_1ex10d3.htm EX-10.3 11139
5 EX-12.1 a09-11040_1ex12d1.htm EX-12.1 38348
6 EX-31.1 a09-11040_1ex31d1.htm EX-31.1 13654
7 EX-31.2 a09-11040_1ex31d2.htm EX-31.2 13236
8 EX-32.1 a09-11040_1ex32d1.htm EX-32.1 6734
9 EX-32.2 a09-11040_1ex32d2.htm EX-32.2 6713
  Complete submission text file 0001104659-09-028173.txt   1335218
Mailing Address 1110 SPRING ST SILVER SPRING MD 20910
Business Address 1110 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS CORP (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 09786564
SIC: 2834 Pharmaceutical Preparations